ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,175Medicare Part D Prescriptions Filled, Including Refills

Rank: 123 out of 6969

$754K Total Retail Price of All Prescriptions

Rank: 240 out of 6969

1,072 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 1,072 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

12% of this provider’s 1,072 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 15,476 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LEVOTHYROXINE SODIUM 1,161 1,114 1 5
AMLODIPINE BESYLATE 1,002 964 2 4
SIMVASTATIN 952 932 3 1
LISINOPRIL 935 900 4 2
LOVASTATIN 440 432 5 15
HYDROCHLOROTHIAZIDE 418 408 6 8
ATENOLOL 413 396 7 9
HYDROCODONE-ACETAMINOPHEN 393 346 S3 8 3
METFORMIN HCL 351 339 9 7
FUROSEMIDE 350 319 10 10
OMEPRAZOLE 333 329 11 6
PANTOPRAZOLE SODIUM 288 282 12 31
SERTRALINE HCL 276 259 13 38
METOPROLOL SUCCINATE 275 264 14 22
LOSARTAN POTASSIUM 218 218 15 12
MELOXICAM 190 170 16 36
TAMSULOSIN HCL 190 185 16 23
ATORVASTATIN CALCIUM 186 163 18 11
GABAPENTIN 186 145 18 17
METOPROLOL TARTRATE 174 173 20 13
FLUTICASONE PROPIONATE 173 171 21 24
RANITIDINE HCL 169 156 22 46
ZOLPIDEM TARTRATE 162 148 23 16
DIOVAN 156 156 24 26
POTASSIUM CHLORIDE 154 149 25 30
DONEPEZIL HCL 153 153 26 32
SPIRIVA 152 147 27 66
GLIPIZIDE 142 139 28 21
TERAZOSIN HCL 141 141 29 49
WARFARIN SODIUM 141 141 29 20
DIGOXIN 137 137 31 71
LORAZEPAM 132 130 32 186
ALLOPURINOL 122 120 33 35
TEMAZEPAM 121 121 34 251
TRIAMTERENE-HCTZ 111 111 35 58
KLOR-CON 10 107 106 36 160
LEVOXYL 101 99 37 122
ALENDRONATE SODIUM 98 94 38 14
CLOPIDOGREL 98 94 38 48
ADVAIR DISKUS 97 83 40 45
TRAZODONE HCL 96 76 41 47
ISOSORBIDE MONONITRATE ER 90 90 42 81
FINASTERIDE 88 88 43 80
ESTRADIOL 87 81 R 44 124
PAROXETINE HCL 84 83 45 65
TRAMADOL HCL 83 81 46 27
PREMARIN 83 83 R 46 156
GLYBURIDE 74 74 R 48 54
ZETIA 73 70 49 98
VENLAFAXINE HCL ER 73 58 49 150
NAPROXEN 71 65 51 62
JANUVIA 70 70 52 41
OXYBUTYNIN CHLORIDE 69 69 53 126
CARVEDILOL 68 62 54 25
ANDROGEL 67 67 S3 55 281
GEMFIBROZIL 67 67 55 85
NAMENDA 67 67 55 51
PLAVIX 62 62 58 68
BENAZEPRIL HCL 61 60 59 18
CIPROFLOXACIN HCL 59 55 60 64
CYMBALTA 55 50 61 72
RAMIPRIL 54 52 62 112
PROAIR HFA 54 50 62 33
FELODIPINE ER 51 48 64 116
VERAPAMIL ER 51 51 64 133
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.